Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating infusion of Umbilical Cord Mesenchymal Stem Cells for initial Type 1 diabetes mellitus, sponsored by Qingdao University…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Umbilical cord mesenchymal stem cell infusion (umbilical cord mesenchymal stem cells)

Snippet

Sponsor: Qingdao University | Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 1 | Phase 1, Phase 2 | Status: UNKNOWN